Free Delivery Over $100
|
|
|||
|
||||
OverviewThe National Cancer Policy Board and the Board on Science, Engineering, and Economic Policy convened a workshop in January 2004 on a /Economic Models of Colorectal Cancer (CRC) Screening in Average-Risk Adultsa . The purpose of the workshop was to explore the reasons for differences among leading cost-effectiveness analysis (CEA) models of CRC screening, which public health policy makers increasingly rely on to help them sift through the many choices confronting them. Participants discussed the results of a collaborative pre-workshop exercise undertaken by five research teams that have developed and maintained comprehensive models of CRC screening in average-risk adults, to gain insight into each modela (TM)s structure and assumptions and possible explanations for differences in their published analyses. Workshop participants also examined the current state of knowledge on key inputs to the models with a view toward identifying areas where further research may be warranted. This document summarized the presentations and discussion at the workshop. Full Product DetailsAuthor: Board on Science, Technology, and Economic Policy , National Cancer Policy Board , Policy and Global Affairs , Institute of MedicinePublisher: National Academies Press Imprint: National Academies Press ISBN: 9780309095396ISBN 10: 0309095395 Pages: 308 Publication Date: 11 April 2005 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1 Front Matter; 2 Workshop Summary; 3 References; 4 Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults; 5 Appendix B Workshop Participants; 6 Appendix C Workshop Speaker and Staff Biographies; 7 Appendix D Overview of Harvard Model--Karen M. Kuntz, ScD; 8 Appendix E Description of the Laudabaum Colorectal Cancer Screening Model--Uri Ladabaum, M.D., M.S; 9 Appendix F MISCAN-colon: An Overview--Marjolein van Ballegooijen, Iris Vogelaar, Rob Boer, Franka Loeve, Ann Zauber, Gerrit van Oortmar, and Dik Habbema; 10 Appendix G The Vanderbilt Colorectal Cancer Model--R.M. Ness, R.W. Klein, R.S. Dittus; 11 Appendix H Overview of the Vijan Colorectal Cancer Screening Model--Sandeep Vijan, M.D., M.S; 12 Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise--Michael Pignone, M.D.,; 13 Appendix J Recent Findings on Test Performance--Brian P. Mulhall, M.D., M.P.H; 14 Appendix K Cost Issues in Cost Effectiveness Modeling of Colorectal Cancer Screening--Martin L. Brown, Ph.D; 15 Appendix L Current Evidence on Compliance --Sally W. Vernon, M.A., Ph.D; 16 Appendix M Recent Trends in Follow-up Surveillance in Medicare Beneficiaries--Todd Anderson, M.S; 17 Appendix N Preliminary Results from CDC; 18 Appendix O Colorectal Cancer Surveillance Testing After Polypectomy--Deborah Schrag, M.D., M.P.H; 19 Appendix P Natural History of Colorectal Adenomas and Cancer--T. R. Levin, M.D; 20 Appendix Q CISNET-Cancer Intervention and Surveillance--Eric J. (Rocky) Feuer, Ph.DReviewsAuthor InformationMichael Pignone, Louise Russell and Judith Wagner, Editors, Institute of Medicine and National Research Council Tab Content 6Author Website:Countries AvailableAll regions |
||||
